RecruitingNCT06324916
Donor Site Morbidity After Free Vascularized Fibular Graft
Long Term Evaluation Of Donor Site Morbidities After Free Vascularized Fibular Graft For Reconstruction Of Any Bone Defect Other Than In The Lower Limb
Sponsor
Assiut University
Enrollment
20 participants
Start Date
Jan 10, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
This study was carried out at Assiut University to Asses the long-term donor site morbidity following free vascularized fibular transfer because there is a limited information regarding the long-term donor morbidity of this type of flap.
Eligibility
Min Age: 18 Years
Inclusion Criteria3
- Patients done FVFG for reconstruction of bone defect other than lower limb bone defect.
- surgery done \>2yrs
- Patient age \> 18 yrs old
Exclusion Criteria1
- Patient age \< 18 Surgery done\< 2yrs FVFG for reconstruction of lower limb bone defct Amputated other leg : Above Ankle Amputaion Double FVFG Fracture of the other leg side : Fracture Tibia, Fibula, Ankle Paraplegic patients
Interventions
RADIATIONXray
X rays for ankle to see distal fibular remenant
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06324916
Related Trials
Apatinib Combined With Liposomal Irinotecan for Refractory or Metastatic Osteosarcoma
NCT074797321 location
A Study of Gefitinib, Trametinib, Disulfiram, and Sunitinib in Addition to Standard Chemotherapy in People With Osteosarcoma
NCT074774577 locations
Upfront Surgical Resection for Osteosarcoma
NCT063844041 location
Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors
NCT066251901 location
Assessment of Healing and Function After Reconstruction Surgery for Bone Sarcomas
NCT034424653 locations